Search Results - "Carleo, Alfonso"
-
1
Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis
Published in Inflammation (01-02-2020)“…Idiopathic pulmonary fibrosis is characterised by abnormal reepithelialisation and remodelling consequent to persistent stimuli or injury. The involvement of…”
Get full text
Journal Article -
2
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy
Published in Scientific reports (10-06-2020)“…Idiopathic pulmonary fibrosis (IPF) is a fatal progressive disease with a median survival of 2–5 years. Nintedanib is a small tyrosine kinase inhibitor that…”
Get full text
Journal Article -
3
Neurodegenerative Disorder Risk in Krabbe Disease Carriers
Published in International journal of molecular sciences (04-11-2022)“…Krabbe disease (KD) is a rare autosomal recessive disorder caused by mutations in the galactocerebrosidase gene ( ). Defective GALC causes aberrant metabolism…”
Get full text
Journal Article -
4
Smooth Muscle Cell Phenotypic Switch Induced by Traditional Cigarette Smoke Condensate: A Holistic Overview
Published in International journal of molecular sciences (29-03-2023)“…Cigarette smoke (CS) is a risk factor for inflammatory diseases, such as atherosclerosis. CS condensate (CSC) contains lipophilic components that may represent…”
Get full text
Journal Article -
5
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases
Published in Clinical and experimental medicine (01-05-2020)“…Bronchoalveolar lavage (BAL) is a useful procedure for differential diagnosis of interstitial lung diseases (ILDs) and for identification of granulomatous lung…”
Get full text
Journal Article -
6
Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication
Published in Frontiers in pharmacology (17-08-2022)“…Idiopathic pulmonary fibrosis (IPF) is a progressive disease with significant mortality and morbidity. Approval of antifibrotic therapy has ameliorated disease…”
Get full text
Journal Article -
7
Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways
Published in International journal of molecular sciences (27-05-2021)“…In the longtime challenge of identifying specific, easily detectable and reliable biomarkers of IPF, BALF proteomics is providing interesting new insights into…”
Get full text
Journal Article -
8
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures
Published in International journal of molecular sciences (04-01-2023)“…Idiopathic pulmonary fibrosis (IPF) is a form of chronic and irreversible fibrosing interstitial pneumonia of unknown etiology. Although antifibrotic…”
Get full text
Journal Article -
9
CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses
Published in Nutrients (22-06-2023)“…Over the last two decades, obesity has reached pandemic proportions in several countries, and expanding evidence is showing its contribution to several types…”
Get full text
Journal Article -
10
Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation
Published in Monaldi archives for chest disease (30-04-2020)“…Acute exacerbations (AEs) are among the main causes of death in idiopathic pulmonary fibrosis (IPF) patients. In this study proteomic comparative analysis of…”
Get full text
Journal Article -
11
Editorial: New insights in sarcoidosis: from bench to bedside
Published in Frontiers in medicine (04-05-2023)Get full text
Journal Article -
12
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls
Published in Proteomics. Clinical applications (01-12-2014)“…Background Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease characterized by progressive loss of the alveolar integrity,…”
Get full text
Journal Article -
13
Correction to: BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases
Published in Clinical and experimental medicine (01-05-2020)“…The original version of this article unfortunately contained a mistake. First and last names of the authors were interchanged…”
Get full text
Journal Article -
14
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment
Published in Biomedicines (24-03-2022)“…Severe eosinophilic asthma is characterized by chronic airway inflammation, oxidative stress, and elevated proinflammatory cytokines, especially IL-5…”
Get full text
Journal Article -
15
First Attempt to Couple Proteomics with the AhR Reporter Gene Bioassay in Soil Pollution Monitoring and Assessment
Published in Toxics (Basel) (29-12-2021)“…A topsoil sample obtained from a highly industrialized area (Taranto, Italy) was tested on the DR-CALUX cell line and the exposed cells processed with…”
Get full text
Journal Article -
16
Biomarkers in sarcoidosis: the contribution of system biology
Published in Current opinion in pulmonary medicine (01-09-2016)“…PURPOSE OF REVIEWSystem biology is an interdisciplinary approach with the purpose to evaluate the experimental results of ‘-omics’ sciences as a whole. The…”
Get full text
Journal Article -
17
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers
Published in Rheumatology (Oxford, England) (01-01-2019)“…Abstract Objective SSc is a rare severe connective tissue disorder. Its prognosis is mainly related to the development of pulmonary fibrosis (PF)-SSc and…”
Get full text
Journal Article -
18
-
19
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab
Published in Biochimica et biophysica acta. Proteins and proteomics (01-02-2021)“…Severe eosinophilic asthma has been associated with Th2 airway inflammation and elevated proinflammatory cytokines and chemokines, such as IL-5. Precision…”
Get full text
Journal Article -
20
Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study
Published in Internal medicine journal (01-05-2021)“…Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease often managed with nintedanib, a tyrosine kinase inhibitor targeting several…”
Get full text
Journal Article